The innate immune response to Entamoeba histolytica lipopeptidophosphoglycan is mediated by toll-like receptors 2 and 4

Parasite Immunology

Volumn 27, Issue 4, 2005, Pages 127-137

  Maldonado Bernal, C ^a   Kirschning, C J ^b   Rosenstein, Y ^c   Rocha, L M ^d   Rios Sarabia, N ^e   Espinosa Cantellano, M ^f   Becker, I ^g   Estrada, I ^h   Salazar Gonzalez R M ^e   Lopez Macias C ^e   Wagner, H ^b   Sanchez J ⁱ   Isibasi, Armando ^e  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^e HOSPITAL DE ESPECIALIDADES   (Mexico)

^f DEPARTAMENTO DE FÍSICA   (Mexico)

^g UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^h INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

ⁱ UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

Author keywords

Entamoeba histolytica; Innate immunity; LPPG; Nuclear factor (NF) B; Pathogen associated molecular pattern (PAMP); Toll like receptor (TLR)

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; DACTINOMYCIN; GLYCAN PHOSPHATE LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; INTERLEUKIN 8; LUCIFERASE; POLYSACCHARIDE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMEBIASIS; ANIMAL MODEL; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; ENTAMOEBA HISTOLYTICA; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION RESISTANCE; INNATE IMMUNITY; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PLASMID; PRIORITY JOURNAL; REPORTER GENE; ROUS SARCOMA ONCOVIRUS;

ANIMALS; ANTIGENS, PROTOZOAN; CELL LINE; ENTAMOEBA HISTOLYTICA; FEMALE; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-8; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MONOCYTES; NF-KAPPA B; PEPTIDOGLYCAN; PHOSPHOLIPIDS; PROTEIN SUBUNITS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; ENTAMOEBA HISTOLYTICA;

EID: 20444371556     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2005.00754.x     Document Type: Article

References (45)

1. Stanley SL Jr. Amoebiasis. Lancet 2003; 361: 1025-1034.
2. Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr. Amoebiasis. N Engl J Med 2003; 348: 1565-1573.
3. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M & Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197: 403-411.
4. Janeway CA Jr. How the immune system works to protect the host from infection: a personal view. Proc Natl Acad Sic 2001; 98: 7461-7468.
5. Underhill DM & Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14: 103-110.
6. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci 2000; 97: 13766-13771.
7. van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122-48129.
8. Campos MA, Almeida IC, Takeuchi O, et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001; 167: 416-423.
9. Ouaissi A, Guilvard E, Delneste Y, et al. The Trypanosoma cruczi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. J Immunol 2002; 168: 6366-6374.
10. Becker I, Salaiza N, Aguirre M, et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol 2003; 130: 65-74.
11. Kammanadiminti SJ, Mann BJ, Dutil L & Chadee K. Regulation of Toll-like receptor-2 expression by the Gal-lectin of Entamoeba histolytica. FASEB J 2004; 18: 155-167.
12. Acosta-Altamirano G, Torres-Sanchez E, Meraz E, Isibasi-Araujo A & Kumate-Rodriguez J. Detection of class IgA antibodies directed against a lipopeptidophosphoglycan of E. histolytica in samples of human colostrum. Arch Invest Med (Mex) 1986; 17 (Suppl. 1): 291-295.
13. Campos-Rodriguez R, Barranco-Tovar C, Isibasi-Araujo A & Kumate-Rodriguez J. Anti-amebic plasma cells in peripheral blood of patients with amebic liver abscess. Arch Invest Med (Mex) 1986; 17 (Suppl. 1): 303-306.
14. Isibasi A, Blanco F, Arreguin C, et al. Immunochemical differences in the surface polysaccharides obtained from Entamoeba histolytica strain HM1:IMSS and its virulent (C-A) and non-virulent (L-6) clones. Arch Invest Med (Mex) 1990; 21 (Suppl. 1): 175-181.
15. Bhattacharya A, Prasad R & Sacks DL. Identification and partial characterization of a lipophosphoglycan from a pathogenic strain of Entamoeba histolytica. Mol Biochem Parasitol 1992; 56: 161-168.
16. Prasad R, Tola M, Bhattacharya S, Sharma MP & Bhattacharya A. Recognition of Entamoeba histolytica lipophosphoglycan by a strain-specific monoclonal antibody and human immune sera. Mol Biochem Parasitol 1992; 56: 279-287.
17. Moody S, Becker S, Nuchamowitz Y & Mirelman D. Virulent and avirulent Entamoeba histolytica and E. dispar differ in their cell surface phosphorylated glycolipids. Parasitology 1997; 114: 95-104.
18. Moody-Haupt S, Patterson JH, Mirelman D & McConville MJ. The major surface antigens of Entamoeba histolytica trophozoites are GPI-anchored proteophosphoglycans. J Mol Biol 2000; 297: 409-420.
19. Isibasi A, Santa CM, Ramirez A & Kumate J. Immunochemistry of a lipopeptidophosphoglycan extracted from trophozoites of Entamoeba histolytica strain HK-9 cultivated in axenic media, using the phenol-water method. Arch Invest Med (Mex) 1982; 13 (Suppl. 3): 51-55.
20. Melzer H, Fortugno P, Mansouri E, et al. Antigenicity and immunogenicity of phage library-selected peptide mimics of the major surface proteophosphoglycan antigens of Entamoeba histolytica. Parasite Immunol 2002; 24: 321-328.
21. Maldonado C, Trejo W, Ramirez A, et al. Lipophosphopeptidoglycan of Entamoeba histolytica induces an antiinflammatory innate immune response and downregulation of toll-like receptor 2 (TLR-2) gene expression in human monocytes. Arch Med Res 2000; 31: S71-S73.
22. Marinets A, Zhang T, Guillen N, et al. Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica. J Exp Med 1997; 186: 1557-1565.
23. Dubois M, Guilles K & Hamilton J. Calorimetric method of determination of sugars and related substances. Analyt Chem 1956; 28: 350-356.
24. Tsai CM & Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Analyt Biochem 1982; 119: 115-119.
25. Keisari Y. A colorimetric microtiter assay for the quantitation of cytokine activity on adherent cells in tissue culture. J Immunol Meth 1992; 146: 155-161.
26. Kirschning CJ, Wesche H, Merrill AT & Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 1998; 188: 2091-2097.
27. Vabulas RM, Braedel S, Hilf N, et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 2002; 277: 20847-20853.
28. Chadee K, Petri WA Jr, Innes DJ & Ravdin JI. Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica. J Clin Invest 1987; 80: 1245-1254.
29. Reed SL, Curd JG, Gigli I, Gillin FD & Braude AI. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica. J Immunol 1986; 136: 2265-2270.
30. Sing A, Rost D, Tvardovskaia N, et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 2002; 196: 1017-1024.
31. Brubaker RR. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 2003; 71: 3673-3681.
32. Ma X & Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells. Adv Immunol 2001; 79: 55-92.
33. Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R beta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002; 168: 5699-5708.
34. Acevedo JA, Pacheco-Yepez J, Serrano-Luna J, Espinosa-Cantellano M, Tsutsumi V & Shibayama M. Experimental amebic liver abscess: in vivo localization of TNF-alpha. Arch Med Res 2000; 31: S98-S100.
35. Campbell D & Chadee K. Survival Strategies of Entamoeba histolytica: Modulation of cell-mediated Immune Responses. Parasitol Today 1997; 13: 184-190.
36. Wang W, Keller K & Chadee K. Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection. Infect Immun 1992; 60: 3169-3174.
37. + T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033-1036.
38. Jones BW, Means TK, Heldwein KA, et al. Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 2001; 69: 1036-1044.
39. Kirschning CJ & Bauer S. Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses. Int J Med Microbiol 2001; 291: 251-260.
40. Zhang G & Ghos S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107: 13-19.
41. Yu Y & Chadee K. Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact. Gastroenterology 1997; 112: 1536-1547.
42. Lauwaet T, Oliveira MJ, De Bruyne G, et al. Entamoeba histolytica trophozoites transfer lipophosphopeptidoglycan to enteric cell layers. Inter J Parasitol 2004; 34: 549-556.
43. Muñoz LE, Botello MA, Carrillo O & Martínez M. Early detection of complication in Amebic Liver Abscess. Arch Med Res 1992; 23: 251-253.
44. Bone RC, Grodzin CJ & Balk RA. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 112: 235-243.
45. Schnare M, Barton GM, Holt AC, Takeda K, Akira S & Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947-950.